Your Article Summary
See Latest ArticlesManagement of long-bone metastases: a surgical perspective
Aging Health, 06/11/09
Al-Ghamdi A et al. - Surgery is sometimes unavoidable to address some of these lesions and will represent a significant challenge for both the patient and the medical team. Patients presenting with bone metastases are a heterogeneous group. Some present late in the course of their disease after failing all treatment modalities whereas others present without a known diagnosis of cancer. Patients will benefit if physicians can recognize lesions at risk of fracture or already fractured, and understand the advantages and the limitations of surgery. Patient selection and the type of procedure performed are of outmost importance. Chances for a satisfactory functional outcome and survival rates following surgery should be known in order to avoid unnecessary procedures that may be associated with significant rates of complication. Appropriate surgical intervention for bone metastases can provide the elderly cancer patient with meaningful palliation and contribute to their overall quality of life.
Related Articles
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
Annals of Oncology, 10/21/09
Relevance Score: 46%
Unique Localization of Circulating Tumor Cells in Patients With Hepatic Metastases
Journal of Clinical Oncology, 11/09/09
Relevance Score: 45%
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer
Acta Oncologica, 11/02/09
Relevance Score: 45%
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology, 10/29/09
Relevance Score: 44%
Clinical Analysis of Novalis Stereotactic Radiosurgery for Brain Metastases
Journal of Korean Neurosurgical Society, 10/30/09
Relevance Score: 43%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
British Journal of Cancer, 12/18/09
Epidermal growth factor signalling and bone metastasis
British Journal of Cancer, 12/18/09
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
Oncogene, 12/17/09